首页|造血干细胞生成免疫细胞的潜力及其应用研究进展

造血干细胞生成免疫细胞的潜力及其应用研究进展

扫码查看
造血干细胞(HSC)具有高度自我更新、增殖和多向分化等潜能。长期以来,HSC移植一直是治疗血液性疾病和自身免疫性疾病的主要方法,而移植后免疫系统的重建能力是评价移植是否成功的关键。为了提高移植后免疫系统的重建能力,目前研究多集中于基因工程,以及利用规律间隔成簇短回文重复序列(CRISPR)基因编辑技术改造HSC作为移植细胞的来源。本文主要对HSC的生物学特性、调控机制、分化为免疫细胞的能力以及在治疗血液、免疫缺陷、癌症等相关疾病的应用及其研究进展进行总结,以期为相关疾病的研究提供参考。
Research progress of haematopoietic stem cells to generate immune cells and its application
Hematopoietic stem cells(HSCs)posses the potential for highly self-renewal,proliferation and multi-lineage differentiation.HSC transplantation has long been the primary method for treating hematologic disorders and autoimmune diseases,and the ability to rebuild the immune system after transplantation is a key indicator of success.To enhance the reconstruction ability of the immune system after transplantation,current research focuses on genetic engineering and the use of HSCs modified by clustered regularly interspaced short palindromic repeats(CRISPR)gene editing technology as a source of transplant cells.This article summaries the biological characteristics,regulatory mechanism,ability to differentiate into immune cells,as well as the application and advance in the treatment of blood disorders,immune deficiencies,cancers and other related diseases,aiming to provide references for the research on relevant diseases.

hematopoietic stem cellimmunegenetic engineeringregulatory mechanismreview

张雅琳、李娟娟、闫鹏辉、周瑾、庄玉洁、张雪梅、王小龙、张君涛、张志平、邓立新

展开 >

河南农业大学动物医学院临床兽医系,河南郑州 450046

河南省银丰生物工程技术有限公司,河南郑州 450000

造血干细胞 免疫细胞 基因工程 调控机制 综述

河南省自然科学基金国家肉牛牦牛产业技术体系建设项目

212300410355CARS-37

2024

细胞与分子免疫学杂志
中国免疫学会,第四军医大学

细胞与分子免疫学杂志

CSTPCD北大核心
影响因子:0.817
ISSN:1007-8738
年,卷(期):2024.40(3)
  • 80